Related Experiment Videos
[Pathology and pathogenesis of multiple sclerosis from the viewpoint of neurologic disease research]
Wiener Medizinische Wochenschrift (1946)
|January 31, 1985
Abstract:
The pathology of multiple sclerosis (MS) is characterized by the trias: inflammation, primary demyelination and reactive gliosis. However, besides these obligatory alterations a high inter- and intraindividual variability of structural aspects is found in MS lesions. Recent experimental studies in a model disease for MS, in chronic relapsing experimental allergic encephalomyelitis, provide a better understanding of the dynamics of lesions development in MS brains.
Insights
Multiple sclerosis (MS) pathology involves inflammation, demyelination, and gliosis, but lesion development shows significant variability. Experimental models help clarify the complex dynamics of these lesions in the brain.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Context:
- Multiple sclerosis (MS) is a chronic neurological disease.
- MS pathology is defined by inflammation, demyelination, and reactive gliosis.
- Significant variability exists in MS lesion structure.
Purpose:
- To investigate the dynamics of lesion development in MS.
- To understand the structural variability in MS lesions.
- To utilize experimental allergic encephalomyelitis (EAE) as a model for MS.
Summary:
- MS lesions exhibit a characteristic triad of inflammation, demyelination, and reactive gliosis.
- Despite these core features, MS lesions display considerable inter- and intraindividual structural variation.
- Studies using chronic relapsing experimental allergic encephalomyelitis (EAE) offer insights into lesion development dynamics.
Impact:
- Enhances understanding of multiple sclerosis pathogenesis.
- Provides a basis for exploring therapeutic targets for MS.
- Contributes to the study of neuroinflammatory and neurodegenerative processes.